|
US Medical device makers eye more acquisitions
Some of the world's leading medical device companies are
actively looking for hot new technologies to fill niches in their product
pipelines, suggesting a flurry of small acquisitions is on the horizon. There is
an accelerating trend of larger companies gobbling up smaller ones, or
partnering with those that have key products in development, said medical
technology executives.
While no one is predicting another blockbuster deal on the order
of Johnson & Johnson's $25.4 billion purchase of Guidant Corp, company
executives see more deals valued in the range of $100 million to $200 million
which focus on emerging technologies.
Medtronic assumes it can achieve its 15 percent annual revenue
and profit growth target over the next five years without an acquisition, but
will continue to look for opportunities to add promising products, technology,
intellectual property or even companies, Collins said.
(Ref : Express Pharma Pulse Dated March 3, 2005)
****
|
